RT Journal Article
SR Electronic
T1 Role of physiotherapy team in critically ill COVID-19 patients pronation: can a multidisciplinary management reduce the complications rate?
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.20.21258949
DO 10.1101/2021.06.20.21258949
A1 Glotta, Andrea
A1 Faldarini, Nicola
A1 Biggiogero, Maira
A1 Saporito, Andrea
A1 Olivieri, Diana
A1 Molteni, Claudia
A1 Petazzi, Stefano
A1 Mauri, Romano
A1 Capdevila, Xavier
A1 Ceruti, Samuele
YR 2021
UL http://medrxiv.org/content/early/2021/06/21/2021.06.20.21258949.abstract
AB Objectives During the pandemic, critically ill COVID-19 patients’ management presented an increased workload for Intensive Care Unit (ICU) nursing staff, particularly during pronation maneuvers, with high risk of complications. In this scenario, a support during pronation by the ICU Physiotherapy Team was introduced.Research methodology Retrospective analysis. Consecutive critically ill COVID-19 patients.Setting A COVID-19 Center in southern Switzerland, between March 16th and April 30th, 2020.Main Outcome Measures Rates and characteristics of pronation-related complications.Results Forty-two patients on mechanical ventilation (MV) were treated; 296 standard prone/supine positioning were performed, with 3.52 cycles/patient. One (0.3%) major complication was observed, while fourteen (33.3%) patients developed minor complications, e.g. pressure injuries. The incidence of pressure sores was related to ICU length-of-stay (LOS) (p = 0.029) and MV days (p = 0.015), while their number (n = 27) further correlated with ICU LOS (p = 0.001) and MV days (p = 0.001). The propensity matching score analysis did not show any protective factor of pronation regarding pressure injuries (p = 0.448). No other significant correlation was found.Conclusion The specific pronation team determined a low rate of major complications in critically ill COVID19 patients. The high rate of minor complications appeared to be related to disease severity, rather than from pronation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors declare that they have funding source for this article.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics Committees: Comitato Etico Cantonale, Via Orico 4, 6500 - Bellinzona Ethical approval was given with the internal referral number: CE_TI 3763 (Chairman Prof. Zanini)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available under specific request